Light therapy for cancer-related fatigue in (non-)Hodgkin lymphoma survivors: results of a randomized controlled trial

Starreveld, D.E.J.; Daniels, L.A.; Kieffer, J.M.; Valdimarsdottir, H.B.; Geus, J. de; Lanfermeijer, M.; ... ; Bleiker, E.M.A. (2021)

Article / Letter to editor

Simple Summary

Cancer-related fatigue (CRF) is one of the most frequently reported symptoms with prevalence rates of 25 to 60 percent in (non-)Hodgkin lymphoma survivors. Several (pilot) studies showed promising effects of light therapy to reduce CRF. The aim of the current study is to evaluate the short- and long-term efficacy of light therapy on CRF and associated symptoms in chronically fatigued (non-)Hodgkin lymphoma survivors. Eighty-three survivors were exposed to bright white light (intervention) and another 83 survivors were exposed to dim white light (comparison). Results showed that all participants, irrespective of light condition, reported reduced levels of fatigue after the completion of light therapy. Similar results were found for depression, sleep quality, and some aspects of quality of life. No effect was found on circadian rhythms or objectively assessed sleep. Therefore, it is important to further investigate which aspects of intervention are associated with the improvements observed after light therapy.

Purpose: To evaluate the short- and long-term effects of light therapy on fatigue (primary outcome) and sleep quality, depression, anxiety, quality of life, and circadian rhythms (secondary outcomes) in survivors of (non-)Hodgkin lymphoma presenting with chronic cancer-related fatigue. Methods: We randomly assigned 166 survivors (mean survival 13 years) to a bright white light intervention (BWL) or dim white light comparison (DWL) group. Measurements were completed at baseline (T0), post-intervention (T1), at three (T2), and nine (T3) months follow-up. A mixed-effect modeling approach was used to compare linear and non-linear effects of time between groups. Results: There were no significant differences between BWL and DWL in the reduction in fatigue over time. Both BWL and DWL significantly (p < 0.001) improved fatigue levels during the intervention followed by a slight reduction in this effect during follow-up (EST0-T1 = -0.71; EST1-T3 = 0.15). Similar results were found for depression, sleep quality, and some aspects of quality of life. Light therapy had no effect on circadian rhythms. Conclusions: BWL was not superior in reducing fatigue compared to DWL in HL and DLBCL survivors. Remarkably, the total sample showed clinically relevant and persistent improvements on fatigue not commonly seen in longitudinal observational studies in these survivors.

• cancer-related fatigue
• light therapy
• circadian rhythms
• sleep
• randomized controlled trial

• All authors: Starreveld, D.E.J.; Daniels, L.A.; Kieffer, J.M.; Valdimarsdottir, H.B.; Geus, J. de; Lanfermeijer, M.; Someren, E.J.W. van; Habers, G.E.A.; Bosch, J.A.; Janus, C.P.M.; Spronsen, D.J. van; Weijer, R.J. de; Marijt, E.W.A.; Jongh, E. de; Zijlstra, J.M.; Bohmer, L.H.; Houmes, M.; Kersten, M.J.; Korse, C.M.; Rossum, H.H. van; Redd, W.H.; Lutgendorf, S.K.; Ancoli-Israel, S.; Leeuwen, F.E. van; Bleiker, E.M.A.
• Date: 2021-10-01
• Journal: Cancers
• Volume: 13
• Issue: 19
• DOI: doi:10.3390/cancers13194948
• Link: https://www.mdpi.com/2072-6694/13/19/4948/pdf